[HTML][HTML] Новые принципы лечения хронической сердечной недостаточности: феномен ингибиторов натрий-глюкозного котранспортера 2-го типа

СГ Канорский - Медицинский совет, 2022 - cyberleninka.ru
Хроническая сердечная недостаточность (ХСН) является одной из важнейших
проблем клинической кардиологии из-за высокой заболеваемости, частых …

Cost Utility Analysis of Dapagliflozin in Egyptian Patients with CKD from the Payer Perspective

G Saadi, M Elsharkawy… - Open Journal of …, 2023 - archive.sdpublishers.com
Background: Chronic kidney disease is a serious public health issue in Egypt. An estimated
13% of individuals in Egypt are expected to have CKD, with a higher prevalence among …

EVALUATION OF NEPRILYSIN, OSTEOPROTEGERIN AND HEART FATTY ACID-BINDING PROTEIN AS PREDICTIVE BIOMARKERS FOR HEART FAILURE IN …

SJ Khudiar, RS Baban… - …, 2024 -  …
Background: Chronic kidney disease (CKD) is a serious disorder that gradually deteriorates
all kidney functions over time. Numerous studies and research have demonstrated that …

Study to Determine the Average Time Taken to Reach End Stage Renal Disease from Mild or Moderate Stages with Different Risk Factors in Chronic Kidney Disease …

B Benny, J George, R Joyson, N Berchmans… - Indian Journal of …, 2023 - ijopp.org
Background: Chronic Kidney Disease (CKD) is a growing global burden that presents a
myriad of complications and is a leading cause of mortality. There are limited studies from …

Contemporary issues in static and dynamic prediction: some applications and evaluation in the clinical context

Y Chen - 2022 - research.rug.nl
Prediction models that estimate the probabilities of developing a specific disease (diagnostic
model) or a specific endpoint of disease (prognostic model) given a set of subject's …

[PDF][PDF] Research Article Effect of Dapagliflozin on Clinical Outcome after Drug-Eluting Stent Implantation in Elderly T2DM Patients: A Real-World Study

Y Lin, F Zhou, X Wang, Y Guo, W Chen - 2023 - scienceopen.com
Objective. To investigate the effect of dapagliflozin therapy on the clinical outcome of drug-
eluting stent (DES) implantation in elderly patients with type 2 diabetes mellitus (T2DM) …

Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease

MS Shamkhalova, OY Sukhareva… - Terapevticheskii …, 2022 - ter-arkhiv.ru
Sodium-glucose cotransporter inhibitors updated their position in the therapy of patients with
type 2 diabetes mellitus due to proven nephro-and cardioprotective effects. The DAPA-CKD …

Chronický kardiorenální syndrom a glifloziny-pohled kardiologa.

J Kořínek, M Dobiáš - Remedia, 2023 - search.ebscohost.com
Kořínek J, Dobiáš M. Chronický kardiorenální syndrom a glifloziny–pohled kardiologa.
Remedia 2023; 33: 250–257. Chronický kardiorenální syndrom (KRS) představuje jeden z …

Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients–A Retrospective Single Center Study

J Freitas, JT Francisco, MT Coimbra… - Brazilian Journal of …, 2024 - bjt.emnuvens.com.br
Introdução: Considerando o aumento da incidência de diabetes pós-transplante eo elevado
impacto cardiovascular entre os receptores de transplantes, este facto faz com que o uso de …

Cardiorenal prevention as the key player in the reduction of all-cause mortality

A Gippini, A Prado - Nefrología (English Edition), 2023 - revistanefrologia.com
Rec ently it has been published in this journal a consensus doc ument about Chronic Kidney
Disease (CKD) management including prevention and treatment strategies of CKD itself and …